Scarica l'app Stockscreener
2.07
0.00%
0.00
Dopo l'orario di chiusura:
2.07
Precedente Chiudi:
$2.07
Aprire:
$2.08
Volume 24 ore:
267.07K
Relative Volume:
1.01
Capitalizzazione di mercato:
$35.86M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-0.48%
1M Prestazione:
+17.61%
6M Prestazione:
-46.92%
1 anno Prestazione:
-36.11%
Intervallo 1D:
$2.07
$2.08
Intervallo di 1 settimana:
$2.07
$2.09
Portata 52W:
$0.95
$4.74
Mural Oncology Plc Stock (MURA) Company Profile
Nome
Mural Oncology Plc
Settore
Industria
Telefono
353 1 905 8020
Indirizzo
10 EARLSFORT TERRACE, DUBLIN 2
Confronta MURA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MURA
Mural Oncology Plc
|
2.07 | 35.86M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.34 | 100.82B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
461.24 | 60.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
575.02 | 60.69B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
752.33 | 46.32B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
327.20 | 36.58B | 3.81B | -644.79M | -669.77M | -6.24 |
Mural Oncology Plc Stock (MURA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-25 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2024-06-28 | Iniziato | Rodman & Renshaw | Buy |
| 2024-04-04 | Iniziato | Morgan Stanley | Overweight |
Mural Oncology Plc Borsa (MURA) Ultime notizie
Citadel Group discloses 1.73% stake in Mural Oncology By Investing.com - Investing.com Australia
Trium Capital discloses 10.55% stake in Mural Oncology By Investing.com - Investing.com Australia
Citadel Group discloses 1.73% stake in Mural Oncology - Investing.com
Trium Capital discloses 10.55% stake in Mural Oncology - Investing.com
Bull Run: Can LDTCW keep up with sector leadersVolume Spike & Real-Time Volume Trigger Notifications - خودرو بانک
Resistance Check: Why is RMBI stock going down2025 Growth vs Value & Comprehensive Market Scan Insights - خودرو بانک
Fundamentals Check: Is Mural Oncology plc a defensive stockQuarterly Performance Summary & Weekly Stock Performance Updates - خودرو بانک
Sentiment Recap: Is Mural Oncology plc stock influenced by commodity prices2025 Stock Rankings & Safe Entry Point Identification - خودرو بانک
Big Picture: What dividend growth rate does Mural Oncology plc offer2025 Geopolitical Influence & AI Driven Price Forecasts - خودرو بانک
Citadel Group discloses 1.75% stake in Mural Oncology - Investing.com India
Dow Update: Can OILU reach all time highs this yearCPI Data & Low Risk High Win Rate Picks - خودرو بانک
Bull Bear: Is Mural Oncology plc a defensive stock2025 Macro Impact & AI Forecast Swing Trade Picks - خودرو بانک
Gains Recap: Can Mural Oncology plc benefit from deglobalizationJuly 2025 Setups & Low Risk Investment Opportunities - خودرو بانک
Citadel Group discloses 1.76% stake in Mural Oncology - Investing.com
Citadel Group discloses 1.76% stake in Mural Oncology By Investing.com - Investing.com Nigeria
Form 8.3The Vanguard Group, Inc.: Mural Oncology plc - MarketScreener
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NWE, GES, MURA, TZUP on Behalf of Shareholders - GlobeNewswire Inc.
Citadel discloses 1.73% stake in Mural Oncology - Investing.com
Citadel discloses 1.73% stake in Mural Oncology By Investing.com - Investing.com Australia
Trium Capital discloses 10.52% stake in Mural Oncology By Investing.com - Investing.com Australia
Trium Capital discloses 10.52% stake in Mural Oncology - Investing.com
Citadel Group discloses 1.74% stake in Mural Oncology By Investing.com - Investing.com Australia
BlackRock discloses 1.61% stake in Mural Oncology By Investing.com - Investing.com Canada
Is Mural Oncology plc stock a good dividend stockWeekly Trend Report & AI Driven Price Predictions - Lancaster City Council
BlackRock discloses 1.61% stake in Mural Oncology - Investing.com
Citadel Group discloses 1.74% stake in Mural Oncology - Investing.com
Mural Oncology plc Stock Recovery Path — Analyst Breakdown2025 Macro Impact & Consistent Return Investment Signals - beatles.ru
Is Mural Oncology plc showing insider buyingWeekly Market Report & Daily Profit Maximizing Tips - beatles.ru
Pattern Scan Adds Mural Oncology plc to Watchlist2025 Top Gainers & Verified Momentum Stock Ideas - beatles.ru
Is Mural Oncology plc’s ROE strong enoughJuly 2025 Gainers & Daily Momentum Trading Reports - 강소기업뉴스
BlackRock discloses stake in Mural Oncology By Investing.com - Investing.com Nigeria
Visual analytics tools that track Mural Oncology plc performanceWeekly Risk Report & Entry Point Confirmation Signals - Newser
Technical signs of recovery in Mural Oncology plc2025 Market WrapUp & Safe Capital Preservation Plans - Newser
What to expect from Mural Oncology plc in the next 30 daysGold Moves & Fast Exit and Entry Strategy Plans - Newser
Sector ETF performance correlation with Mural Oncology plcPortfolio Growth Summary & Daily Growth Stock Tips - Newser
Heatmap analysis for Mural Oncology plc and competitorsQuarterly Portfolio Review & Risk Managed Investment Strategies - Newser
Is Mural Oncology plc vulnerable to short sellersRisk Management & Weekly Hot Stock Watchlists - خودرو بانک
Citadel Group discloses 1.68% stake in Mural Oncology By Investing.com - Investing.com Canada
Will Mural Oncology plc benefit from rising consumer demand2025 Major Catalysts & Advanced Swing Trade Entry Plans - خودرو بانک
Can Mural Oncology plc be the next market leaderEarnings Trend Report & Weekly Stock Performance Updates - خودرو بانک
Is it time to cut losses on Mural Oncology plc2025 EndofYear Setup & Proven Capital Preservation Methods - Newser
Is Mural Oncology plc reversing from oversold territory2025 Price Momentum & Fast Gain Stock Trading Tips - Newser
What institutional flow reveals about Mural Oncology plc2025 Year in Review & Smart Allocation Stock Reports - Newser
Is Mural Oncology plc exposed to currency risksGap Up & Low Risk Profit Maximizing Plans - خودرو بانک
BlackRock discloses 1.62% stake in Mural Oncology By Investing.com - Investing.com Australia
Citadel Group discloses 1.65% stake in Mural Oncology By Investing.com - Investing.com Australia
Citadel Group discloses 1.68% stake in Mural Oncology - Investing.com India
Boston M&A in August Mural Oncology, UWill and scPharmaceuticals - The Business Journals
Mural Oncology Plc Azioni (MURA) Dati Finanziari
Non sono disponibili dati finanziari per Mural Oncology Plc (MURA). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
Mural Oncology Plc Azioni (MURA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Keson-Brookes Maiken | See Remarks |
Jul 18 '25 |
Sale |
2.48 |
2,158 |
5,352 |
71,406 |
0.58%
1.73%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):